ADHERENCE AND PERSISTENCE TO TREATMENT WITH INFLIXIMAB: ANALYSIS OF A PATIENT SUPPORT PROGRAM COHORT IN BRAZIL.

Aniela Bonorino Xexeo Castelo Branco Wilton Argolo Nathalia Santos Gabriela Hernandez Adriana Maria Kakehasi Carlos Walter Sobrado Junior Richard Melsheimer

Published in: Arquivos de gastroenterologia (2024)

Many patients leave the program without discontinuing IFX, since the 12-month persistence were very different between program and medication estimates, while high adherence rates were observed among patients enrolled in the PSP. Data highlights the benefits of a PSP.

Keyphrases

quality improvement
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
case report
emergency department
big data
patient reported outcomes
artificial intelligence
ulcerative colitis
smoking cessation